Second Generation LipoSonix System for Body Contouring

LipoSonix System for Body Contouring

A second generation LipoSonix system for nonsurgical aesthetic waist circumference reduction received FDA approval in October.
The LipoSonix system is in the process of being acquired by Solta Medical from Medicis Technologies Corporation.
The system uses high-intensity focused ultrasound energy to permanently destroy below skin fat in the abdominal area. It can be effective in getting rid of love handles.
The treatment is noninvasive and nonsurgical and typically lasts an hour. There is no need for anesthesia and there is no downtime.
During treatment, a doctor places the head of the LipoSonix system on the area to be treated. High-intensity ultrasound energy is then focused on the targeted fat.
Ultrasound energy penetrates the skin without damaging it targeting just the fat tissue beneath the skin, which is permanently destroyed. The body then naturally processes and permanently removes the destroyed fat tissue over a period of 8 to 12 weeks.
Clinical studies conducted by Medicis Technologies Corporation showed an average waist circumference reduction of approximately 2.6 cm, corresponding to one dress or pant size, after a single treatment with the LipoSonix system. Results are typically seen in 8 to 12 weeks.
Adverse side-effects experienced included procedural pain, post–procedural pain, bruising and swelling. These were mostly mild, short–lived in duration, and resolved without incident.
There were no serious adverse events or unanticipated adverse device effects.
The LipoSonix treatment is not a replacement for liposuction surgery or a healthy lifestyle, or a way to lose weight. No special diet or exercise program is required.
"Compared to its predecessor, the second generation LipoSonix system provides a treatment area that is 2.7 times as large for faster treatment times, has improved ergonomics and ease of use for the practitioner, and has a much smaller footprint in the physician's office," said Stephen J. Fanning, Chairman, President & CEO of Solta Medical.
According to the American Society for Aesthetic Plastic Surgery (ASAPS), liposuction represented the second highest number of surgical cosmetic procedures in 2010 with over 280,000 procedures.
Solta Medical is a global leader in the medical aesthetics market. Its other products include Thermage and Fraxel.

  • Digg
  • StumbleUpon
  • Reddit
  • RSS